menu
    • menu

    Company profile for Inventiva Pharma

    NEW Drugs in Dev: 4
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. We have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant exp...
    We are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. We have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Inventiva PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    50 rue de Dijon 21121 Daix,
    Telephone
    Telephone
    +33 (0)3 80 44 75 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://inventivapharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/inventiva-pharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/inventivapharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inventiva Submits Its 2025 URD and Annual Report
    Inventiva Submits Its 2025 URD and Annual Report

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270486/0/en/Inventiva-announces-filing-of-its-2025-Universal-Registration-Document-and-2025-Annual-Report-on-Form-20-F.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Inventiva Reports 2025 Full-Year Results And Business Update
    Inventiva Reports 2025 Full-Year Results And Business Update

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3265019/0/en/Inventiva-reports-2025-full-year-results-and-provides-a-business-update.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Inventiva Presentation of its 2025 Full-Year Financial Results
    Inventiva Presentation of its 2025 Full-Year Financial Results

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260878/0/en/Inventiva-Schedules-the-Publication-and-Presentation-of-its-2025-Full-Year-Financial-Results.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Inventiva Reports Preliminary 2025¹ Fiscal Year Financial Results
    Inventiva Reports Preliminary 2025¹ Fiscal Year Financial Results

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3238953/0/en/Inventiva-reports-preliminary-2025-fiscal-year-financial-results.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Inventiva To Present At Guggenheim Biotech Summit 2026
    Inventiva To Present At Guggenheim Biotech Summit 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3232443/0/en/Inventiva-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Inventiva's 50% Surge Shows Investor Optimism Over Liver Drug
    Inventiva's 50% Surge Shows Investor Optimism Over Liver Drug

    28 Jan 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/biotech-inventivas-50-surge-shows-investor-optimism-over-liver-disease-drug-2026-01-28/

    REUTERS
    28 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search